Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
Merck
Colorcon
Teva
Moodys
Cipla
Farmers Insurance
Novartis
Federal Trade Commission

Generated: January 21, 2018

DrugPatentWatch Database Preview

AZTREONAM Drug Profile

« Back to Dashboard

Which patents cover Aztreonam, and what generic alternatives are available?

Aztreonam is a drug marketed by Fresenius Kabi Usa and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in AZTREONAM is aztreonam. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aztreonam profile page.
Drug patent expirations by year for AZTREONAM
Pharmacology for AZTREONAM
Ingredient-typeMonobactams
Drug ClassMonobactam Antibacterial
Medical Subject Heading (MeSH) Categories for AZTREONAM

US Patents and Regulatory Information for AZTREONAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa AZTREONAM aztreonam INJECTABLE;INJECTION 065439-002 Jun 18, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int AZTREONAM aztreonam INJECTABLE;INJECTION 065286-001 Mar 23, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa AZTREONAM aztreonam INJECTABLE;INJECTION 065439-003 Jun 18, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa AZTREONAM aztreonam INJECTABLE;INJECTION 065439-001 Jun 18, 2010 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int AZTREONAM aztreonam INJECTABLE;INJECTION 065286-002 Mar 23, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Teva
Moodys
Johnson and Johnson
Cantor Fitzgerald
Federal Trade Commission
Novartis
Dow
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot